PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19
Authors
Keywords
-
Journal
Communications Biology
Volume 5, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-12
DOI
10.1038/s42003-022-03766-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo
- (2021) Courtney L. Finch et al. Microorganisms
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
- (2020) Yixuan J. Hou et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
- (2020) Timothy P. Sheahan et al. Science Translational Medicine
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
- (2020) Laura Riva et al. NATURE
- Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2
- (2020) Yuan-Lin Kang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis
- (2020) Eric J. Snijder et al. PLOS BIOLOGY
- Identification of required host factors for SARS-CoV-2 infection in human cells
- (2020) Zharko Daniloski et al. CELL
- A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice
- (2020) Sarah R. Leist et al. CELL
- Arbidol and other Low Molecular Weight Drugs That Inhibit Lassa and Ebola Viruses
- (2019) C. E. Hulseberg et al. JOURNAL OF VIROLOGY
- A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis
- (2019) Gaurav Sharma et al. Autophagy
- scmap: projection of single-cell RNA-seq data across data sets
- (2018) Vladimir Yu Kiselev et al. NATURE METHODS
- Massively parallel digital transcriptional profiling of single cells
- (2017) Grace X. Y. Zheng et al. Nature Communications
- The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection
- (2017) Elizabeth A. Nelson et al. PLoS Neglected Tropical Diseases
- Causal analysis approaches in Ingenuity Pathway Analysis
- (2013) Andreas Krämer et al. BIOINFORMATICS
- The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies
- (2013) S. Gierer et al. JOURNAL OF VIROLOGY
- Brief Report: A phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis
- (2011) Sarah Krausz et al. ARTHRITIS AND RHEUMATISM
- Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
- (2010) S. Matsuyama et al. JOURNAL OF VIROLOGY
- Plasmacytoid Dendritic Cells Control Lung Inflammation and Monocyte Recruitment in Indirect Acute Lung Injury in Mice
- (2009) Fabienne Venet et al. AMERICAN JOURNAL OF PATHOLOGY
- Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohnʼs disease
- (2009) Bruce E. Sands et al. INFLAMMATORY BOWEL DISEASES
- Standardized Preparation of Single-Cell Suspensions from Mouse Lung Tissue using the gentleMACS Dissociator
- (2009) Melanie Jungblut et al. Jove-Journal of Visualized Experiments
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started